Treatment of hypertension with angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross‐sectional study

Journal of Clinical Hypertension ◽

10.1111/jch.14392 ◽

2021 ◽

Author(s):

Pablo B. Pedrianes‐Martin ◽

Marcos Martin‐Rincon ◽

David Morales‐Alamo ◽

Ismael Perez‐Suarez ◽

Mario Perez‐Valera ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Resting Metabolic Rate ◽

Angiotensin Converting Enzyme Inhibitors ◽

Cross Sectional Study ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Cross Sectional ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in the treatment of hypertension: Adding more fuel for the fire?

European Journal of Preventive Cardiology ◽

10.1177/2047487317739052 ◽

2017 ◽

Vol 24 (18) ◽

pp. 1911-1913 ◽

Cited By ~ 2

Author(s):

Ricardo Fontes-Carvalho

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?

Current Vascular Pharmacology ◽

10.2174/157016110793563924 ◽

2010 ◽

Vol 8 (6) ◽

pp. 742-746 ◽

Cited By ~ 7

Author(s):

Paolo Verdecchia ◽

Fabio Angeli ◽

Giovanni Mazzotta ◽

Giuseppe Ambrosio ◽

Gianpaolo Reboldi

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be used together?

Current Vascular Pharmacology ◽

10.2174/1570210206263431611 ◽

2010 ◽

Vol 999 (999) ◽

pp. 1-5

Author(s):

Paolo Verdecchia ◽

Fabio Angeli ◽

Giovanni Mazzotta ◽

Giuseppe Ambrosio ◽

Gianpaolo Reboldi

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2017.11.006 ◽

2018 ◽

Vol 42 (2) ◽

pp. 118-123 ◽

Cited By ~ 3

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Angiotensin Converting Enzyme ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Cancer Epidemiology ◽

10.1016/j.canep.2009.10.005 ◽

2009 ◽

Vol 33 (5) ◽

pp. 391-395 ◽

Cited By ~ 14

Author(s):

E.R. Koomen ◽

R.M.C. Herings ◽

H.J. Guchelaar ◽

T. Nijsten

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Melanoma Incidence ◽

Receptor Blockers

Download Full-text

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Journal of Clinical Hypertension ◽

10.1111/jch.14329 ◽

2021 ◽

Author(s):

Na Jia ◽

Guifang Zhang ◽

Xuelin Sun ◽

Yan Wang ◽

Sai Zhao ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Systemic Review ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

All Cause Mortality ◽

Receptor Blockers

Download Full-text

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2012.00687.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 731-731 ◽

Cited By ~ 1

Author(s):

John J.V. McMurray ◽

Robert M. Califf ◽

Angelyn M. Bethel ◽

Steven M. Haffner ◽

Rury R. Holman

Keyword(s):

Cohort Study ◽

Angiotensin Converting Enzyme ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN COVID-19 –META-ANALYSIS/META-REGRESSION ADJUSTED FOR CONFOUNDING FACTORS

CJC Open ◽

10.1016/j.cjco.2021.03.001 ◽

2021 ◽

Author(s):

TERRY LEE ◽

A CAU ◽

MP CHENG ◽

A LEVIN ◽

TC LEE ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Angiotensin Converting Enzyme Inhibitors ◽

Confounding Factors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Meta Regression

Download Full-text

Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

American Heart Journal ◽

10.1016/j.ahj.2004.04.037 ◽

2004 ◽

Vol 148 (5) ◽

pp. 747-754 ◽

Cited By ~ 47

Author(s):

Sverre E. Kjeldsen ◽

Stevo Julius

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

End Points ◽

Receptor Blockers

Download Full-text